Hi RN.
I will play devil's advocate here. Is it though? The HIV self-test kit range is becoming more and more competitive by the month.
I read a long list of HIV rapid kit products.
HIV rates are falling slowly, while more and more products are coming online.
Atomo has the advantage of being early, but most third world countries are going to go with what is cheapest.
I see the HIV line as ultimately being high margin. Atomo will get its shot but its a crowded space.
The diversity among disease solutions Atomo can create will be the key factor.
AT1 FY21 - General Discussion + FA, page-968
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $17.25M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $3.145K | 116.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 863000 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 60000 | 1 |
View Market Depth
| Last trade - 15.12pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.7¢ |
Change
-0.002 ( 6.90 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.8¢ | 2.7¢ | 301050 | ||
| Last updated 14.30pm 05/06/2024 ? | |||||
| AT1 (ASX) Chart |